Recent Cymbalta News & Press Releases

Generic Cymbalta Available for Sale

March 17, 2005

United Pharmacies are now selling Generic Cymbalta with prices starting at $7.00 per strip of 10 tablets. Symbal is manufactured by manufactured by Torrent Pharmaceuticals and is available in 20mg, 30 mg and 40mg dosages. [Buy Generic Cymbalta]

Generic Cymbalta to be Manufactured by Torrent Pharmaceuticals

November 12, 2004

Torrent Pharmaceutical have announced they will manufacture Generic Cymbalta. the new drug will be called Symbal and will be available in 20mg, 30mg and 40mg dosages. [Read More]

FDA Approves Cymbalta for the Treatment of Depression

September 18, 2004

Prescription Cymbalta is not for everyone. People who are allergic to duloxetine hydrochloride or the other ingredients in Cymbalta should not take it. If you are taking thioridazine or if you are taking or have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), you should not take Cymbalta. [Read More]

EU Scientific Committee Recommends Approval of Cymbalta® and Xeristar® for Treatment of Major Depressive Episodes

September 17, 2004

Eli Lilly and Company and Boehringer Ingelheim today announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes. The CHMP has recommended that the European Commission authorize the drug to be marketed. If approved, this pharmaceutical treatment for depression will be marketed throughout the European Union by Lilly under the brand name Cymbalta® and by Boehringer Ingelheim under the brand names Cymbalta and, in Greece, Italy and Spain, as Xeristar®. [Read More]

Drug May Avert Surgery for Severe Incontinence

September 16, 2004

Women awaiting surgery to relieve severe stress urinary incontinence may gain significant relief with the drug, leading some to reconsider surgery, a study indicates. Cymbalta (Duloxetine) has previously been shown to be effective in women with mild to moderate stress urinary incontinence. [Read More]

New Antidepressant Targets Physical Symptoms Too

September 15, 2004

Depression is more than mood. It can come with physical symptoms that might surprise you. The government has approved a new antidepressant called Cymbalta designed to attack the emotional problem and more. "But it treated the physical symptoms that I have, that I had all the way along with my depression, pain in my shoulders, back and neck," says Randi Bradstreet, a Cymbalta patient. [Read More]

New Antidepressant Aids Fibromyalgia Sufferers

September 9, 2004

A new antidepressant called duloxetine improved symptoms of fibromyalgia -- a chronic and painful musculoskeletal disorder in women. [Read More]

Cymbalta Approved for Diabetic Peripheral Neuropathy Pain (DPNP)

September 8, 2004

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy. Cymbalta comes in a capsule and can be taken once a day. The recommended daily dose for Cymbalta is 60 mg. In addition to depression and pain caused by diabetic peripheral neuropathy, duloxetine hydrochloride, the active ingredient in Cymbalta, also has been approved in Europe for the treatment of moderate to severe stress urinary incontinence, another condition believed to respond to treatment that affects serotonin and norepinephrine levels. [Read More]

Cymbalta News. Current News about Cymbalta (Duloxetine HCl) from Eli Lilly.